INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics (UNCY) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

ATLANTA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC has filed a shareholder class action lawsuit against Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (NASDAQ:UNCY). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information, including allegations that: (i) Unicycive’s readiness and ability to satisfy the FDA’s manufacturing compliance requirements was overstated; (ii) the OLC NDA’s regulatory prospects were likewise overstated; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

If you purchased shares of Unicycive between March 29, 2024 and June 27, 2025, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by visiting the firm’s website at www.holzerlaw.com/case/unicycive-therapeutics/ for more information.

The deadline to ask the court to be appointed lead plaintiff in the case is October 14, 2025.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.